Skip to main content

Table 5 Comparison of Harrell’s concordance index between TNM stage and prognostic models based on PET/MRI biomarkers

From: Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy

 

OS

PFS

c-index

95% CI

c-index

95% CI

TNM stage

0.56

0.49–0.62

0.53

0.45–0.61

PET/MRI model for OS

0.79*

0.66–0.91

  

PET/MRI model for PFS

  

0.70**

0.60–0.80

  1. *P = 0.002 in comparison with TNM stage
  2. ** P = 0.047 in comparison with TNM stage
  3. CI = confidence interval; OS = overall survival; PFS = progression-free survival